Mehdi Karoui
Prof Mehdi Karoui is an expert in Surgery at Assistance Publique - Hôpitaux de Paris (France). As of October 2026, ScienceLeadR ranks Mehdi Karoui in the top 1% of experts worldwide for Intestinal Neoplasms, Gastrointestinal Neoplasms and Colonic Diseases. Mehdi Karoui has authored 247 publications, the most recent in 2026, and is an investigator in 20 clinical trials, 7 of them ongoing. SLR score: 886 (community average: 125). How the SLR is computed.
LeadR Profile
Surgery
Subspecialties: Gastroenterology - Oncology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1998 - 2026
Number : 247
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Contrast-enhanced CT colonography in colon cancer: expanding roles in staging, surgical planning and clinical decision-making. PMID 42640277 — clinical decision-making, neoplasms, colon, decision making, diagnostic imaging, colonography, computed tomographic, therapeutics, colonic neoplasms | Abdom Radiol (NY) | 2026 | 0 |
| Minimally invasive pancreatectomy with mesentericoportal venous resection: Results from a French national cohort. PMID 42414185 — liver diseases, mortality, blood, operative time, morbidity, pancreatectomy | HPB (Oxford) | 2026 | 0 |
| Predicting Best Performers After Minimally Invasive Left Pancreatectomy: Insights From a National Cohort. PMID 42237086 — mortality, minimally invasive surgical procedures, reoperation, general surgery, pancreatectomy | Ann Surg | 2026 | 0 |
| How do surgeons manage sigmoid volvulus electively? Results of a nationwide practice survey (AFC-SFCD-FRENCH). PMID 42112581 — colon, sigmoid, intestinal volvulus, colorectal surgery, surgeons | Colorectal Dis | 2026 | 0 |
| Organ Preservation in Rectal Cancer Management: A Prospective GRECCAR Snapshot. PMID 42053078 — disease-free survival, organ preservation, neoplasms, neoplasm metastasis, neoadjuvant therapy, rectal neoplasms, therapeutics | Dis Colon Rectum | 2026 | 0 |
Clinical Studies 20
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Cohort/Consortium Investigators 10
Ongoing Clinical Trials
7 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| PRODIGE 90 FFCD 22024 PREDIR NEOREC Neoadjuvant dostarlimab with short course radiotherapy in a watch and wait strategy for microsatellite unstable or mismatch repair deficient locally advanced rectal cancer patients a randomized phase II trial 2024-510772-20-00 — radiotherapy, dna mismatch repair, microsatellite repeats, neoplasms, rectal neoplasms, mmr-deficient | Phase 2 | Recruiting | 2025 |
| Low Powered Colorectal Anastomosis After Rectal Excision (OASIS) NCT07146334 — neoplasms, cohort studies, rectal neoplasms, anastomotic leak | N/A | Not yet recruiting | 2025 |
| PRODIGE 90 (FFCD 2204) Neoadjuvant Dostarlimab with Short Course Radiotherapy in a Watch and wait Strategy for Microsatellite Unstable or Mismatch Repair deficient Locally Advanced Rectal Cancer Patients NCT06762405 — cytokines, radiotherapy, dna mismatch repair, microsatellite repeats, blood, circulating tumor dna, neoplasms, adenocarcinoma, drug therapy, immunotherapy, rectal neoplasms, exome, therapeutics, tissues, infusions, intravenous, dna, microbiota, microsatellite instability, chemotherapy, mmr-deficient, msi-h | Phase 3 | Recruiting | 2025 |
| Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer NCT06123156 — radiotherapy, neoplasms, rehabilitation, sildenafil citrate, rectum, proctectomy, rectal neoplasms, blood platelets | Phase 3 | Recruiting | 2025 |
| Neoadjuvant Chemotherapy for Obstructive Colon cancER First Treated by cOlostomy NCT06107920 — colostomy, neoplasms, colon, drug therapy, chemotherapy, adjuvant, neoadjuvant therapy, therapeutics, colectomy, colonic neoplasms, chemotherapy | Phase 3 | Recruiting | 2024 |
LeadR Networks
Main global connection map